Salahop, Marsifilena C.

HRN: 22-70-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2023
CEFTAZIDIME 1GM (VIAL)
03/08/2023
03/14/2023
IV
1gm
Q8
CAP MR
Waiting Final Action 
03/12/2023
AZITHROMYCIN 500MG TABLET (TAB)
03/12/2023
03/16/2023
PO
500mg
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: